Curaleaf Holdings announced on Dec. 22 that Curaleaf CEO Joseph Lusardi had exercised options to purchase 900,114 subordinate voting shares (SVS) of the company's common stock on Dec. 7. As a result, the total number of options exercised by Lusardi increased to the equivalent of 3.5 million shares in 2020. SVS refers to the restricted shares that carry a right to vote where another class of shares outstanding carries a greater right to vote, on a per-share basis. Additionally, Lusardi sold 500,000 shares on Dec. 17 to accommodate personal year-end tax planning.